Across TCGA pan-cancer cohorts, CNOT10-AS1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CNOT10-AS1’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where CNOT10-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CNOT10-AS1 is over-expressed in tumor.
COAD, UCEC, and BRCA are the cancer types where CNOT10-AS1 tumor–normal differential expression is most reproducible.